Cargando…
Activated T cell therapy targeting glioblastoma cancer stem cells
Naïve T cells become effector T cells following stimulation by antigen-loaded dendritic cells (DCs) and sequential cytokine activation. We aimed to develop procedures to efficiently activate T cells with tumor-associated antigens (TAAs) to glioblastoma (GBM) stem cells. To remove antigen presentatio...
Autores principales: | Miyaguchi, Ken, Wang, Hongqiang, Black, Keith L., Shiao, Stephen L., Wang, Rongfu, Yu, John S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9814949/ https://www.ncbi.nlm.nih.gov/pubmed/36604465 http://dx.doi.org/10.1038/s41598-022-27184-w |
Ejemplares similares
-
Emerging targets for glioblastoma stem cell therapy
por: Safa, Ahmad R., et al.
Publicado: (2016) -
Analysis of gene expression and chemoresistance of CD133(+ )cancer stem cells in glioblastoma
por: Liu, Gentao, et al.
Publicado: (2006) -
Cancer stem cells in glioblastoma
por: Lathia, Justin D., et al.
Publicado: (2015) -
Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells
por: Ma, Yufang, et al.
Publicado: (2017) -
Repurposing Clemastine to Target Glioblastoma Cell Stemness
por: Sun, Michael A., et al.
Publicado: (2023)